Anthropic (ANTHRO) has acquired Coefficient Bio, a biotech focused on developing AI models for biological research, for slightly more than $400M, according to The Information and a report from Eric Newcomer.
Coefficient Bio, comprising about 10 people, is set to join Anthropic’s (ANTHRO) Health Care Life Sciences team led by Eric Kauderer-Abrams following the all-stock buyout deal.
The New York-based company, half-owned by the venture capital firm Dimension, was formally launched only eight months ago by Samuel Stanton and Nathan C. Frey. In the past, the duo had worked in computational drug discovery at the drug discovery unit of Roche’s (RHHBY) (RHHBF) Genentech unit.
The deal represents Amazon (AMZN) and Google (GOOG) (GOOGL)-backed Anthropic’s (ANTHRO) latest foray into healthcare.
In October, the company introduced Claude for Life Sciences, an AI-based tool for scientific discoveries, just months after hiring longtime industry veteran Kauderer-Abrams as its head of biology and life sciences.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.